HBW Advisory Services LLC purchased a new stake in shares of The Clorox Company (NYSE:CLX – Free Report) during the 3rd quarter, according to its most recent filing with the SEC. The institutional investor purchased 375 shares of the company’s stock, valued at approximately $61,000.
Several other hedge funds also recently added to or reduced their stakes in the company. SG Americas Securities LLC boosted its position in shares of Clorox by 1,525.7% during the first quarter. SG Americas Securities LLC now owns 65,612 shares of the company’s stock valued at $10,046,000 after buying an additional 61,576 shares during the period. Mizuho Markets Americas LLC grew its position in Clorox by 93.7% in the 1st quarter. Mizuho Markets Americas LLC now owns 72,053 shares of the company’s stock valued at $11,032,000 after acquiring an additional 34,864 shares during the last quarter. CANADA LIFE ASSURANCE Co increased its stake in Clorox by 15.2% in the first quarter. CANADA LIFE ASSURANCE Co now owns 141,622 shares of the company’s stock worth $21,705,000 after purchasing an additional 18,687 shares during the period. Advisors Asset Management Inc. lifted its position in shares of Clorox by 257.5% during the first quarter. Advisors Asset Management Inc. now owns 11,228 shares of the company’s stock worth $1,719,000 after purchasing an additional 8,087 shares during the last quarter. Finally, Game Plan Financial Advisors LLC purchased a new stake in shares of Clorox during the first quarter valued at $1,025,000. 78.53% of the stock is currently owned by institutional investors.
Clorox Price Performance
Shares of NYSE CLX opened at $161.57 on Friday. The firm has a market cap of $20.07 billion, a PE ratio of 83.72, a PEG ratio of 3.31 and a beta of 0.41. The Clorox Company has a one year low of $114.68 and a one year high of $169.09. The firm has a fifty day moving average of $154.91 and a 200 day moving average of $144.43. The company has a debt-to-equity ratio of 5.04, a quick ratio of 0.63 and a current ratio of 1.03.
Clorox Dividend Announcement
The company also recently disclosed a quarterly dividend, which will be paid on Thursday, November 7th. Investors of record on Wednesday, October 23rd will be issued a $1.22 dividend. This represents a $4.88 dividend on an annualized basis and a dividend yield of 3.02%. The ex-dividend date is Wednesday, October 23rd. Clorox’s dividend payout ratio is currently 252.85%.
Wall Street Analysts Forecast Growth
CLX has been the subject of a number of research analyst reports. JPMorgan Chase & Co. decreased their price objective on shares of Clorox from $150.00 to $148.00 and set a “neutral” rating for the company in a report on Friday, August 2nd. BNP Paribas upgraded shares of Clorox to a “strong sell” rating in a report on Friday, September 6th. Wells Fargo & Company cut their price objective on shares of Clorox from $135.00 to $130.00 and set an “underweight” rating on the stock in a report on Wednesday, July 10th. Deutsche Bank Aktiengesellschaft upped their target price on Clorox from $144.00 to $151.00 and gave the stock a “hold” rating in a report on Friday, August 2nd. Finally, DA Davidson reiterated a “neutral” rating and issued a $153.00 price target on shares of Clorox in a report on Friday, September 6th. Six research analysts have rated the stock with a sell rating, ten have given a hold rating and one has assigned a buy rating to the company’s stock. According to data from MarketBeat.com, the company currently has a consensus rating of “Hold” and a consensus target price of $146.13.
View Our Latest Report on Clorox
Insider Buying and Selling at Clorox
In other news, EVP Angela C. Hilt sold 1,733 shares of Clorox stock in a transaction that occurred on Friday, September 6th. The shares were sold at an average price of $165.52, for a total transaction of $286,846.16. Following the sale, the executive vice president now owns 13,471 shares of the company’s stock, valued at approximately $2,229,719.92. The trade was a 0.00 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. 0.51% of the stock is currently owned by company insiders.
Clorox Company Profile
The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.
Further Reading
- Five stocks we like better than Clorox
- Most Volatile Stocks, What Investors Need to Know
- 3 Key Stocks to Ride China’s Stimulus-Driven Growth
- The Risks of Owning Bonds
- 3 Dividend Growth Stocks Set to Supercharge Your Portfolio
- The 3 Best Fintech Stocks to Buy Now
- 3 Small-Cap Stocks on the Way to Bigger and Better Days
Want to see what other hedge funds are holding CLX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Clorox Company (NYSE:CLX – Free Report).
Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.